-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Helus Pharma, Raises Price Target to $22

Benzinga·10/22/2026 15:26:30
Listen to the news
Wells Fargo analyst Benjamin Burnett maintains Helus Pharma (NASDAQ:HELP) with a Overweight and raises the price target from $16 to $22.